Cargando…

Comparative study of gabapentin and isoflavone in menopausal vasomotor symptoms

OBJECTIVE: This study was planned to compare the effects of gabapentin and isoflavones in menopausal vasomotor symptoms. MATERIALS AND METHODS: This prospective comparative study was conducted on 100 patients with complaints of hot flashes, divided into two groups of 50 each. Group I received 900 mg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singhal, Savita Rani, Shullai, Wansalan Kuru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051233/ https://www.ncbi.nlm.nih.gov/pubmed/27721641 http://dx.doi.org/10.4103/0976-7800.191017

Ejemplares similares

Combined Red Clover isoflavones and probiotics potently reduce menopausal vasomotor symptoms
por: Lambert, Max Norman Tandrup, et al.
Publicado: (2017)

Vasomotor Symptoms: More Than Temporary Menopausal Symptoms
por: Ryu, Ki-Jin, et al.
Publicado: (2020)

Premenstrual Disorders, Timing of Menopause, and Severity of Vasomotor Symptoms
por: Yang, Yihui, et al.
Publicado: (2023)

Association of Menopausal Vasomotor Symptoms With Increased Bone Turnover During the Menopausal Transition
por: Crandall, Carolyn J, et al.
Publicado: (2011)

Hops for Menopausal Vasomotor Symptoms: Mechanisms of Action
por: Abdi, Fatemeh, et al.
Publicado: (2016)

Short-Term Isoflavone Intervention in the Treatment of Severe Vasomotor Symptoms after Surgical Menopause: A Case Report and Literature Review
por: Teekachunhatean, Supanimit, et al.
Publicado: (2015)

Vasomotor and physical menopausal symptoms are associated with sleep quality
por: Kim, Min-Ju, et al.
Publicado: (2018)

Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
por: Umland, Elena M, et al.
Publicado: (2012)

Psychosomatic and vasomotor symptom changes during transition to menopause
por: Augoulea, Areti, et al.
Publicado: (2019)

MON-387 Pheochromocytoma Masquerading as Vasomotor Menopausal Symptoms
por: Xhikola, Majlinda, et al.
Publicado: (2019)

Investigation of the relationship between personality characteristics and vasomotor symptoms in menopausal women
por: Ghorbani, Mahboubeh, et al.
Publicado: (2016)

RANKL is a new Epigenetic Biomarker for the Vasomotor Symptom During Menopause
por: Kalkan, R, et al.
Publicado: (2020)

Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN
por: Thurston, Rebecca C., et al.
Publicado: (2021)

Neurokinin 3 receptor antagonists for menopausal vasomotor symptoms, an appraisal
por: Gompel, Anne, et al.
Publicado: (2023)

Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
por: Pinkerton, JoAnn V, et al.
Publicado: (2023)

Treatment Strategies for Reducing the Burden of Menopause-Associated Vasomotor Symptoms
por: Umland, Elena M.
Publicado: (2008)

A dietary intervention for vasomotor symptoms of menopause: a randomized, controlled trial
por: Barnard, Neal D., et al.
Publicado: (2023)

Acupuncture for menopausal vasomotor symptoms: study protocol for a randomised controlled trial
por: Pirotta, Marie, et al.
Publicado: (2014)

Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review
por: Utian, Wulf H
Publicado: (2005)

The Impact of Soy Isoflavone Supplementation on the Menopausal Symptoms in Perimenopausal and Postmenopausal Women
por: Khapre, Shrutika, et al.
Publicado: (2022)

Association of menopausal vasomotor symptom severity with sleep and work impairments: a US survey
por: DePree, Barbara, et al.
Publicado: (2023)

Comparative Efficacy of Zolpidem and Nigella Sativa in Treatment of Sleep Disorder and Vasomotor Symptoms in Menopausal Women of Women’s General Hospital
por: Asadi, Mojgan, et al.
Publicado: (2020)

Erratum to: Acupuncture for menopausal vasomotor symptoms: study protocol for a randomised controlled trial
por: Pirotta, Marie, et al.
Publicado: (2015)

Variation in menopausal vasomotor symptoms outcomes in clinical trials: a systematic review
por: Iliodromiti, S, et al.
Publicado: (2019)

Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial
por: Neal-Perry, Genevieve, et al.
Publicado: (2023)

Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause
por: Conklin, Melissa, et al.
Publicado: (2023)

“Veozah (Fezolinetant): A Promising Non‐Hormonal Treatment for Vasomotor Symptoms in Menopause”
por: Shaukat, Ayesha, et al.
Publicado: (2023)

Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause
por: Pinkerton, JoAnn V., et al.
Publicado: (2015)

Nonpharmacologic, nonherbal management of menopause-associated vasomotor symptoms: an umbrella systematic review (protocol)
por: Goldstein, Karen M., et al.
Publicado: (2016)

Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions
por: Pachman, Deirdre R, et al.
Publicado: (2010)

Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives
por: Khan, Saira J, et al.
Publicado: (2023)

Potential role of gabapentin and extended-release gabapentin in the management of menopausal hot flashes
por: Yadav, Manisha, et al.
Publicado: (2013)

Global cross-sectional survey of women with vasomotor symptoms associated with menopause: prevalence and quality of life burden
por: Nappi, Rossella E., et al.
Publicado: (2021)

Prevalence, severity, and associated factors in women in East Asia with moderate-to-severe vasomotor symptoms associated with menopause
por: Yu, Qi, et al.
Publicado: (2022)

Vasomotor and other menopause symptoms and the prevalence of ideal cardiovascular health metrics among premenopausal stage women
por: Choi, Hye Rin, et al.
Publicado: (2023)

Women’s views about physical activity as a treatment for vasomotor menopausal symptoms: a qualitative study
por: Thomas, Adèle, et al.
Publicado: (2020)

The Comparative Study of the Administration of the Combination Preparation of Isoflavones and Hyaluronic Acid in Menopausal Women for the Treatment of the Symptoms of Menopause, Urogenital Atrophy and Oteoporosis in Relation to Existing Hormone Replacement Therapies
por: Chalkidou, Anna, et al.
Publicado: (2023)

Protocol for systematic review and meta-analysis: hop (Humulus lupulus L.) for menopausal vasomotor symptoms
por: Abdi, Fatemeh, et al.
Publicado: (2016)

Erratum to: Nonpharmacologic, nonherbal management of menopause-associated vasomotor symptoms: an umbrella systematic review (protocol)
por: Goldstein, Karen M., et al.
Publicado: (2016)

Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review
por: Carranza-Lira, Sebastián
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_bk1bphekv0g9a0asp5o2trie82